Extend the inventors monopoly beyond the period necessary to give him such reward as stimulates invention, and the patent system becomes a clog upon the public interest -- a mere instrumentality ...

Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...

The Federal Circuit rejected a recent argument that the PTAB does not have inter partes review (IPR) jurisdiction over expired patents. Because ...

Without such a promise, the monopoly power inherent in a patent encompassing a globally agreed-upon technology would enable unchecked monopoly power over the entire market for access to the standard.